Summary Background: Where evidence is required for disease-area prioritisation (e.g. by national policymakers), impact on health related quality of life (HRQoL) can be considered equitably across diseases using quantitative data from generic HRQoL instruments. Before this can take place, it must be shown that the instrument captures HRQoL impairment associated with each disease area.
Introduction
Quantification of the wider burden of illness on society, including consideration of health-related quality of life (HRQoL), has become more important as the overall health of the population has improved. Methods of comparison of HRQoL are divided broadly into generic and disease-specific subtypes. Generic instruments examine broad domains that are not specific to any single disease area, allowing the comparison of individuals across disease areas, taking account of co-morbidity and using a common scale. Thus, where evidence is required for prioritisation of disease areas (for example by national policymakers), potential impact on HRQoL can be considered equitably across diseases using quantitative data. In contrast, disease-specific instruments are generally more sensitive instruments but are less appropriate in general population studies which include large numbers of patients who do not have the disease in question.
Prior to comparison of generic HRQoL across disease areas, the ability of the generic instrument to represent HRQoL in each disease area should be examined. EQ-5D
1 was chosen for the present study because it generates a single index of generic HRQoL; a requirement for use in economic analyses (such as the QALY or quality adjusted life year approach) across diseases. Other advantages include its brevity (estimated to take less than 5 min to complete 2 ) and ease of administration. So far, although EQ-5D has been used in general populations without reference to a specific disease area, 3, 4 and in secondary care patients, 5, 6 it has not been tested in a general population with reference to clinical symptoms of respiratory disease.
Aim
To ascertain whether the health related quality of life impairment associated with respiratory disease is represented by responses to EQ-5D, a generic health related quality of life questionnaire.
Method
A postal questionnaire comprising EQ-5D 7 and a modified version of the European Community Respiratory Health Questionnaire 8 (by the addition of questions regarding family history and smoking habits) was sent in 2001 to all patients (10,471) over the age of 16 years registered with two neighbouring general practices in South Manchester. A covering letter on practice headed paper was included, with the respondents name and address printed individually, describing the questionnaire survey and its purpose in research and resource planning. A postpaid reply envelope was included. Up to two reminders were sent, 4 and 8 weeks after the initial mailing.
The respiratory questionnaire asks about the occurrence of respiratory symptoms over the last 12 months and the presence of risk factors for respiratory disease. 9 The likelihood of a patient having obstructive airways disease was assessed according to the number of symptoms/risk factors reported from six key questions. Validation testing found the reporting of four or more symptoms/risk factors gave a positive predictive value of 0.75 for meriting a trial of obstructive airways disease medication. 10 The six key questions were as follows:
(1) Have you had wheezing or whistling in your chest at any time in the last 12 months? (2) Have you woken up with a feeling of tightness in your chest in the last 12 months? (3) Have you been woken by an attack of shortness of breath at any time in the last 12 months? (4) Have you been woken by an attack of coughing at any time in the last 12 months? (5) Has any person in your family (parents, grandparents, sisters, brothers, or your children) had asthma? (6) Have you ever had hay fever or eczema?
Thus respondents who reported four or more of these symptoms/risk factors were termed 'likely obstructive airways disease'.
EQ-5D was designed for self-completion and asks respondents to rate their function via a single question in each of 5 domains. Domain response combinations are conventionally reported in the order mobility (MO), self-care (SC), usual activities (UA), pain/discomfort (PD) and anxiety/depression (AD). HRQoL is rated at one of three levels: (1) (best possible, no problems), (2) (intermediate, some problems) or (3) (worst possible, severe problems), producing 243 (3 5 ) combinations ranging from 11111 (best possible, no problems on any domain) to 33333 (worst possible, severe problems on all domains).
The modelling of valuations for a subset of combinations of responses (health states) has been achieved by surveying members of the public and applying preference analysis tools such as the time trade-off technique or the standard gamble. The values for the sample of states are extrapolated to form a 'tariff of valuations' for all possible combinations of responses. The values used in this study are those of Dolan et al. 11, 12 ranging from À0.59 to 1.00, where 0 represents a state equivalent to death, a negative value represents a state 'worse than death' and 1 represents 'perfect health'. This measure of HRQoL is referred to as EQ-5D index .
The second part of the instrument requires participants to rate their own quality of life on a thermometer-like 20 cm visual analogue scale (VAS) from 0 ('worst imaginable health state') to 100 ('best imaginable health state') and is referred to as EQ-5D vas .
Differences in proportions for categorical variables were examined using w 2 tests. Differences in the two measures of health-related quality of life (single index value, EQ-5D index and visual analogue scale, EQ-5D vas ) between subgroups were examined using t-tests for differences in means (the reasons for this choice are discussed later) and KruskallWallis tests for differences in ordinal subgroups. Associations between age and HRQoL were examined using Spearman's rank correlation coefficient. Analyses were conducted using SPSS for Windows software. 13 Ethical approval for this study was obtained from South Manchester Local Research Ethics Committee.
Results
In total, 10,471 questionnaires were sent out. After two reminders, although 6828 responses were received, only 5944 (87%) had complete data for EQ-5D. This represents an overall usable response rate of 56.8%.
Respondents ranged in age from 16 to 99 with a mean age of 48.5 years (SD 19.4), with more females (54.9%) than males (45.1%). Non-respondents were younger than respondents (mean age 37.6 compared to 48.5, t-test Po0:001) and more likely to be male (55.1%, w 2 95.6 Po0:001). A significantly smaller proportion of non-respondents were aged 60 or more than for respondents (9.2% vs 30.1% w 2 587.7 Po0:001).
Of those who returned the questionnaire, relatively small proportions failed to complete the EQ-5D domain questions. The highest proportion of missing values was found for the self-care domain (5.7%), followed by anxiety/depression (4.4%), usual activities (4.3%), pain/discomfort (4.1%) and mobility (3.9%). A larger proportion (6.3%) of respondents did not complete the visual analogue scale (EQ-5D vas ). Table 1 shows the proportion of respondents reporting problems in each domain by gender and age. In general, women reported problems in one or more of the five domains more frequently than men and recorded significantly lower values on EQ-5D vas . Both EQ-5D index and EQ-5D vas were found to decrease significantly with advancing age although the correlations were modest (Spearman's rho ¼ À0.41, Po0:001 and À0.34, Po0:001; respectively). Table 2 shows the proportion of respondents reporting problems in each domain by reported respiratory symptoms and likely obstructive airways disease (four or more symptoms/risk factors). The presence of any of the respiratory symptoms was associated with problems in the five EQ-5D domains and thus respiratory symptoms were also associated with lower values of both EQ-5D index and EQ-5D vas . Those considered likely to have obstructive airways disease (reporting four or more symptoms/risk factors) also had significantly lower mean domain derived scores and visual analogue scale scores (mean EQ-5D index 0.63 compared to 0.82, t-test Po0:001; mean EQ-5D vas 62.7 compared to 77.6, t-test Po0:001). Figures 1 and 2 show the frequency distributions of EQ-5D index in those defined as likely and unlikely obstructive airways disease respectively. Both distributions were markedly skewed towards the maximal value of 1.0, although this was more Table 1 The proportion of respondents reporting problems (level 2 or 3) in each domain by age and gender along with the mean value of EQ-5D index and the mean value for EQ-5D vas . 
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pronounced for those unlikely to have obstructive airways disease. The corresponding frequency distributions for EQ-5D vas are shown in Figs. 3 and 4 . Among those who did record a value for EQ-5D vas there was considerable terminal digit preference, with a majority of respondents (77.9%) choosing a value ending in 0 or 5. This resulted in non-normal distributions of values irrespective of respiratory disease status. The distribution of EQ-5D vas in those unlikely to have obstructive airways disease was skewed towards maximal HRQoL, although less so than EQ-5D index in this group. However, the distribution of EQ-5D vas in those likely to have obstructive airways disease more closely resembled a normal distribution. Tables 3 and 4 show mean values of EQ-5D index and EQ-5D vas in those deemed likely and not likely to have obstructive airways disease respectively, stratified by age and gender for respondents aged up to 84 years old. The number of respondents aged 85 years and over was too small to permit meaningful stratified analysis. In all cases, HRQoL was reduced in those respondents with likely obstructive airways disease compared to respondents of the same gender and age category who were unlikely to have obstructive airways disease. The deficit in HRQoL associated with increasing age was much more pronounced in those who reported four or more respiratory symptoms or risk factors.

Discussion
This study has found that health related quality of life measured using the EuroQol EQ-5D instrument is substantially reduced in respondents who report common respiratory symptoms and in those who are likely to have obstructive airways disease. The association with obstructive airways disease remained following stratification of the analysis by age and gender. In addition, the deficit in HRQoL associated with respiratory symptoms increased with increasing age. Confirmation that EQ-5D is showing impaired HRQoL in those with respiratory problems will enable its relationship with a diseasespecific instrument to be quantified. The apparent increase in the impact of respiratory symptoms on generic HRQoL with advancing age could be due to a number of factors. Firstly, it is possible that there are differences in the respiratory symptoms themselves in older respondents; for example there is likely to be a higher prevalence of COPD compared with asthma and the differences in symptomatology may account for this interaction. Secondly, the likelihood of a respondent having one or more co-morbid conditions is likely to increase with advancing age and thus lead to greater impairment of HRQoL. In addition, factors associated with ageing may lower the extent to which respiratory (and other) symptoms can be tolerated. Other factors such as the perception that it is natural for old people to have problems in the domains in question may have led to higher reporting and thus greater apparent impairment of HRQoL. However, it is also possible that other perceptions play a partFfor example that although the respondent may have some difficulties, they are on a par with others of their age. This is likely to be more relevant when considering a respondent's overall rating of their HRQoL on EQ-5D vas .
A similar interaction where individuals with asthma had a greater worsening of HRQoL with advancing age has been reported previously using a disease-specific questionnaire (St George's Respiratory Questionnaire) 14 and was considered to be a reflection of co-morbidity. Co-morbidity has been found to be a determinant of HRQoL in older asthma and COPD patients. 15 The study by Ferrer et al.
14 generated normative general population values for a disease-specific instrument to take account of the fact that even individuals without formal respiratory disease may report some degree of impairment on the diseasespecific instrument. This approach could also assist in the prioritisation of disease areas especially if the normative values on the disease-specific instrument could be translated to those of a generic instrument. A respiratory questionnaire based on one used widely in previous population surveys (and validated for this purpose) enabled identification of respondents with likely obstructive airways disease, in addition to examining HRQoL in the presence of respiratory symptoms. The questionnaire was validated for 'meriting a trial of obstructive airways disease medication'. The questions used for categorisation of respiratory disease focus on asthma symptoms, although respondents with a diagnosis of COPD (or another respiratory illness producing similar symptoms) may also be categorised as likely obstructive airways disease. The issue of diagnosis and labelling in the setting of ). Additional strategies to improve the response rate are costly and could affect the relationship between the General Practitioner (on whose behalf the letters were sent) and the patient.
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The selection of the study population was based on registration with two particular general practices and it is possible that this has led to some selection bias. The age profile of those included in the analysis was compared with that of the local population estimates for wards (voting districts) in England in mid 1998 20 produced by the Social Disadvantage Research Group of Oxford University and found to be very similar. It was not possible to compare the gender profiles in a similar way, and it is likely that the study population contained a higher proportion of females, potentially overestimating of the overall quality of life impairment.
Missing data resulted in 13% of the returned questionnaires being unsuitable for analysis. The 'self-care' question was missed significantly more often, possibly reflecting an unwillingness to report the implicit dependence on others. A larger proportion of respondents did not complete the visual analogue scale. This task is unusual and respondents may not have fully understood how to complete it. The provision of an example may improve response, but it may also have the effect of introducing bias by implying a 'correct' response.
Among those who recorded a value for EQ-5D vas there was considerable terminal digit preference, with 77.9% of respondents choosing a value ending in zero or five. This has been reported in relation to blood pressure measurement 21 but little is known about its effects in the measurement of HRQoL. This phenomenon results in a non-normal distribution of responses which complicates analysis of both EQ-5D vas and EQ-5D index data. The use of the ttest for differences in means has been shown to stand up to violations of normality 22 and the use of mean values also enables comparison with other publications.
Multivariate analysis may have provided more detailed evidence of a statistically significant impairment of HRQoL in those likely to have obstructive airways disease, but this was not attempted due to the non-normal distributions of EQ-5D index and EQ-5D vas . Problems with the nonnormality of the distribution of EQ-5D data are not unique to this study 23, 24 and non-parametric methods have been recommended for use with population samples. 25 Despite the limitations of this study, it has been shown that HRQoL impairment associated with the presence of respiratory symptoms can be represented by responses to the generic questionnaire EQ-5D. It is also clear that EQ-5D is a valuable tool for assessment of generic health-related quality of life in population surveys. The provision of a numeric single index measure of HRQoL enables analysis of individual survey results and also of longitudinal studies (to examine change within individuals over time). Further investigation of EQ-5D in the context of respiratory disease should be conducted by concurrent administration with a disease-specific instrument in a population known to have respiratory problems and analysis of comorbidity may shed further light on the interaction of age and respiratory symptoms.
